Clinical Characteristics and Outcome of COVID-19 in Turkish Hematological Malignancy Patients
Retrospective 340 patients with hematological malignancy in Turkey, showing higher mortality with HCQ treatment.
Confounding by time is likely because more HCQ patients were earlier in time when overall treatment protocols were significantly worse.
This study is excluded in the after exclusion results of meta
analysis:
substantial
confounding by time likely due to declining usage over the early stages of the pandemic when overall treatment protocols improved dramatically.
risk of death, 399.2% higher, RR 4.99, p = 0.003, treatment 35, control 140.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Çivriz Bozdağ et al., 15 Sep 2021, retrospective, Turkey, peer-reviewed, 62 authors.
Abstract: ResearchTJH-2021-0287.R2
doi: 10.4274/tjh.galenos.2021.2021.0287
pr
oo
f
Clinical Characteristics and Outcome of COVID-19 in Turkish Hematological
Malignancy Patients
Çivriz Bozdağ S. et al: OVID-19 in Hematological Malignancies
1
rre
ct
ed
Sinem Çivriz Bozdağ1, Güldane Cengiz Seval2, İpek Yonal-Hindilerden3, Fehmi
Hindilerden4, Neslihan Andıç5, Mustafa Baydar6, Lale Aydın Kaynar7, Selami Toprak8,
Hasan Göksoy9, Berrin Balık10, Ufuk Demirci11, Ferda Can12, Vildan Özkocaman13, Eren
Gündüz14, Tuğba Zeynep Güven15, Zübeyde Nur Özkurt16, Sinan Demircioğlu17, Meral
Beksaç18, İdris İnce19, Umut Yılmaz20, Hilal Eroğlu Küçükdiler21, Elgün Abishov22,
Boran Yavuz23, Ünal Ataş24, Yaşa Gül Mutlu25, Volkan Bas26, Hava Üsküdar Teke27,
Vildan Gürsoy28, Serhat Çelik29, Rafiye Çiftçiler30, Münci Yagcı31, Pervin Topçuoğlu32,
Özcan Çeneli33, Hamza Abbasov34, Cem Selim35, Muhlis Cem Ar36, Kemal Orhan
Yüce37, Sevil Sadri38, Canan Albayrak39, Nil Güler40, Muzaffer Keklik41, Hatice Terzi42,
Ali Doğan43, Arzu Zeynep Yegin44, Meltem Kurt Yüksel45, Sadri Sogol46, İrfan
Yavaşoğlu47, Hüseyin Beköz48, Tekin Aksu49, Senem Maral50, Veysel Erol51, Leylagül
Kaynar52, Osman İlhan53, Ali Zahit Bolaman54, Gökmen Ömür Sevindik55, Arzu Akyay56,
Muhit Özcan57, Günhan Gürman58, Şule Ünal59, Yasemin Yavuz60, Reyhan Diz
Küçükkaya61, Güner Hayri Özsan62
Ankara University, Ankara, Turkey
Ankara University Faculty of Medicine, Department of Hematology, Ankara, Turkey
3
İstanbul University Faculty of Medicine, Department of Internal Medicine, İstanbul, Turkey
4
University of Health Sciences Turkey, Bakırköy Dr. Sadi Konuk Training and Research
Hospital, Clinic of Hematology, İstanbul, Turkey
5
Osmangazi University Faculty of Medicine, Department of Hematology, Eskişehir, Turkey
6
Erciyes University Faculty of Medicine, Kayseri, Turkey
7
Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey
8
Ankara University School of Medicine, Ankara, Turkey
9
Yeni Yüzyıl University Özel Gaziosmanpaşa Hospital, Division of Haematology,
Department of Internal Medicine, İstanbul, Turkey
10
Medipol Mega Hospital, Turkey
11
Trakya University, Edirne, Turkey
12
Ministry of Health Ankara City Hospital, Ankara, Turkey
13
Uludağ University School of Medicine, Division of Hematology, Department of Internal
Medicine, Bursa, Turkey
14
Eskisehir Osmangazi University School of Medicine Department of Hematology, Eskişehir,
Turkey
15
Erciyes University, Kayseri, Turkey
un
co
2
16
Gazi University Department of Hematology, Ankara, Turkey
Necmettin Erbakan University, Meram School of Medicine, Hematology
Meram School of Medicine, Konya, Turkey
18
Ankara University Faculty of Medicine, Ankara, Turkey
19
Dr Ersin Arslan Training and Research Hospital, Gaziantep, Turkey
20
Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine - Department of Internal
Medicine, Division of Hematology
21
Adnan Menderes University, Department of Hematology, Aydın, Turkey
22
Yeni Yüzyıl University, Özel Gaziosmanpaşa Hospital, Istanbul, Turkey
23
Dokuz Eylül University, İzmir, Turkey
24
Akdeniz University, Antalya, Turkey
25
İstanbul Medipol University, Department of Hematology, İstanbul, Turkey
26
Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey
27
Uludağ University Faculty of Medicine, Department of Internal medicine, Bursa, Turkey
28
Eskişehir Osmangazi University Faculty of Medicine, Department of Hematology,
Eskişehir, Turkey
29
Bursa, Turkey
30
Erciyes..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit